Last updated on January 2018

PARALLAX Study, a clinical research study for adults with Hypoparathyroidism.

Brief description of study

We are looking for adults 18 years of age and older with hypoparathyroidism (at time of consent) to take part in a clinical research study. The purpose of the PARALLAX Study is to measure the safety and tolerability of an injectable study drug and its effects on calcium levels in the blood and the amount of calcium passed in the urine, in adults with hypoparathyroidism, when given once a day versus twice a day. 

Each individual will be evaluated to determine his or her eligibility. Those who qualify will receive the study drug and study-related medical care at no cost to them. Participants may also be reimbursed for travel expenses. 

Clinical Study Identifier: TX155533

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.